Abstract
Background: Cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has been described as the standard therapy that improves the outcome of a patient with peritoneal metastasis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
